VIGONVITA-B (02630) announced that the stabilization period for its global offering ended on December 3, 2025 (the 30th day after the deadline for the Hong Kong public offering application). No over-allocation of H-shares occurred in the international offering. Neither the stabilization agent nor any party acting on its behalf undertook any price-stabilizing actions during the stabilization period. The sponsor and global coordinator (acting for itself and on behalf of the international underwriters) did not exercise the over-allotment option, which lapsed on December 3, 2025. Consequently, no H-shares were or will be issued by the company under the over-allotment option.